首页 > 最新文献

Itch (Philadelphia, Pa.)最新文献

英文 中文
Assessment of pruritus in atopic dermatitis: validation of the Severity of Pruritus Scale (SPS) 特应性皮炎瘙痒的评估:瘙痒严重程度量表(SPS)的验证
Pub Date : 2018-06-01 DOI: 10.1097/itx.0000000000000013
G. Yosipovitch, E. Simpson, A. Bushmakin, J. Cappelleri, T. Luger, S. Ständer, W. Tom, K. Benjamin, W. Ports, A. Tallman, H. Tan, R. Gerber
Introduction: Pruritus, or itch, is a central feature of atopic dermatitis (AD) and is often cited as the most bothersome symptom. The Severity of Pruritus Scale (SPS) is a 4-point rating scale adapted from the Atopic Dermatitis Severity Index to provide a measure of pruritus severity within a 24-hour recall period. The objective of this analysis was to assess the qualitative and quantitative validity of the SPS in AD. Methods: Content validity of the SPS was evaluated qualitatively in US patients with AD. Psychometric properties of the SPS were evaluated using data from 2 phase 3 trials conducted to investigate crisaborole in mild to moderate AD (study AD-301: NCT02118766; study AD-302: NCT02118792). Results: Fourteen patients were included in the qualitative analysis, considered adequate because of the single-item, single-concept nature of the SPS. Itch was the most prevalent symptom, and the SPS was easily understood and completed in US English (n=9) and US Spanish (n=5). The psychometric analysis used data from 1344 patients. Test-retest reliability analysis identified an intraclass correlation coefficient of 0.54 for a single SPS observation, and at least 0.70 when at least 2 SPS observations were averaged. SPS scores correlated with Investigator’s Static Global Assessment (ISGA) scores, measures of quality of life, and 4 of 5 signs of AD (Pearson correlations, ≥0.40 at day 29). The difference in score between the no disease group/clear (ISGA 0) and the severe disease group (ISGA 4) was 0.80. The clinically important difference was estimated to be 0.20 and the clinically important response was estimated to be at least a 0.19-point reduction from baseline. Discussion: The SPS is an appropriate tool to assess itch in patients with AD and is a valid and reliable measure of pruritus severity.
简介:瘙痒是特应性皮炎(AD)的主要特征,也是最令人烦恼的症状。瘙痒严重程度量表(SPS)是一个4分的评分量表,改编自特应性皮炎严重程度指数,以提供24小时回忆期内瘙痒严重程度的测量。本分析的目的是评估SPS在AD中的定性和定量有效性。方法:对美国AD患者的SPS内容效度进行定性评价。SPS的心理测量特性评估使用了两项研究crisaborole治疗轻中度AD的3期试验的数据(研究AD-301: NCT02118766;研究AD-302: NCT02118792)。结果:14例患者被纳入定性分析,由于SPS的单项目、单概念性质,被认为是足够的。瘙痒是最常见的症状,美国英语(n=9)和美国西班牙语(n=5)的SPS易于理解和完成。心理测量分析使用了来自1344名患者的数据。重测信度分析表明,单次SPS观测的类内相关系数为0.54,至少2次SPS观测的类内相关系数为0.70。SPS评分与研究者静态全局评估(ISGA)评分、生活质量测量和AD 5个体征中的4个相关(Pearson相关性,第29天≥0.40)。无病/清组(ISGA 0)与重病组(ISGA 4)的评分差异为0.80。临床重要差异估计为0.20,临床重要反应估计至少比基线降低0.19点。讨论:SPS是一种评估AD患者瘙痒的合适工具,也是一种有效可靠的瘙痒严重程度测量方法。
{"title":"Assessment of pruritus in atopic dermatitis: validation of the Severity of Pruritus Scale (SPS)","authors":"G. Yosipovitch, E. Simpson, A. Bushmakin, J. Cappelleri, T. Luger, S. Ständer, W. Tom, K. Benjamin, W. Ports, A. Tallman, H. Tan, R. Gerber","doi":"10.1097/itx.0000000000000013","DOIUrl":"https://doi.org/10.1097/itx.0000000000000013","url":null,"abstract":"Introduction: Pruritus, or itch, is a central feature of atopic dermatitis (AD) and is often cited as the most bothersome symptom. The Severity of Pruritus Scale (SPS) is a 4-point rating scale adapted from the Atopic Dermatitis Severity Index to provide a measure of pruritus severity within a 24-hour recall period. The objective of this analysis was to assess the qualitative and quantitative validity of the SPS in AD. Methods: Content validity of the SPS was evaluated qualitatively in US patients with AD. Psychometric properties of the SPS were evaluated using data from 2 phase 3 trials conducted to investigate crisaborole in mild to moderate AD (study AD-301: NCT02118766; study AD-302: NCT02118792). Results: Fourteen patients were included in the qualitative analysis, considered adequate because of the single-item, single-concept nature of the SPS. Itch was the most prevalent symptom, and the SPS was easily understood and completed in US English (n=9) and US Spanish (n=5). The psychometric analysis used data from 1344 patients. Test-retest reliability analysis identified an intraclass correlation coefficient of 0.54 for a single SPS observation, and at least 0.70 when at least 2 SPS observations were averaged. SPS scores correlated with Investigator’s Static Global Assessment (ISGA) scores, measures of quality of life, and 4 of 5 signs of AD (Pearson correlations, ≥0.40 at day 29). The difference in score between the no disease group/clear (ISGA 0) and the severe disease group (ISGA 4) was 0.80. The clinically important difference was estimated to be 0.20 and the clinically important response was estimated to be at least a 0.19-point reduction from baseline. Discussion: The SPS is an appropriate tool to assess itch in patients with AD and is a valid and reliable measure of pruritus severity.","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"3 1","pages":"e13"},"PeriodicalIF":0.0,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/itx.0000000000000013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42266332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Effect of crisaborole topical ointment, 2%, on atopic dermatitis–associated pruritus: an extended analysis of 2 phase 3 clinical trials crisaborole外用软膏(2%)治疗特应性皮炎相关瘙痒的效果:2项3期临床试验的扩展分析
Pub Date : 2018-06-01 DOI: 10.1097/itx.0000000000000012
G. Yosipovitch, E. Simpson, H. Tan, R. Gerber, T. Luger, S. Ständer, W. Tom, J. Cappelleri, A. Bushmakin, W. Ports, A. Tallman
Introduction: Pruritus is an essential feature of atopic dermatitis (AD) and is widely considered the most distressing symptom. Crisaborole ointment is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate AD. The efficacy of crisaborole for AD-associated pruritus was assessed in 2 phase 3 trials using the Severity of Pruritus Scale (SPS). Post hoc validation of the SPS identified that 1 SPS observation provided inadequate test-retest reliability. Therefore, extended analyses were conducted using at least 2 SPS observations for robust assessment of pruritus in the phase 3 crisaborole trials. Methods: Data were analyzed from 2 identically designed, vehicle-controlled, double-blind, phase 3 trials designed to investigate the efficacy and safety of crisaborole in AD patients aged 2 years and above (AD-301: NCT02118766; AD-302: NCT02118792). At least 2 SPS observations were averaged for acceptable test-retest reliability. Results: At least 2 baseline observations were available for 569 patients in AD-301 and 561 patients in AD-302. Median time to pruritus improvement (SPS score ⩽1 with at least 1-point improvement from baseline) was shorter with crisaborole than with vehicle (AD-301: 5.0 vs. 10.0 d, P=0.0003; AD-302: 6.0 vs. 9.0 d, P=0.0087). At week 4, more crisaborole-treated patients than vehicle-treated patients experienced pruritus improvement (AD-301: 37% vs. 21%, P<0.0001; AD-302: 34% vs. 21%, P=0.0006), mean pruritus scores were lower with crisaborole than with vehicle (AD-301: 0.97 vs. 1.28, P<0.0001; AD-302: 1.08 vs. 1.35, P<0.0001), and more crisaborole-treated patients than vehicle-treated patients experienced a clinically important pruritus response (AD-301: 75% vs. 57%, P<0.0001; AD-302: 72% vs. 64%, P=0.0828). Conclusions: These extended analyses show that patients treated with crisaborole experienced rapid and clinically relevant improvement in AD-associated pruritus.
引言:瘙痒是特应性皮炎(AD)的一个基本特征,被广泛认为是最令人痛苦的症状。Crisaborole软膏是一种非甾体磷酸二酯酶4抑制剂,用于治疗轻度至中度AD。在2项3期试验中,使用瘙痒严重程度量表(SPS)评估了Crisaborol治疗AD相关瘙痒的疗效。SPS的事后验证发现,1个SPS观察结果提供的重新测试可靠性不足。因此,在3期交叉口试验中,使用至少2个SPS观察结果进行了扩展分析,以对瘙痒进行稳健评估。方法:分析2项相同设计的、载体对照的、双盲的3期试验的数据,这些试验旨在研究克里斯aborole治疗2岁及以上AD患者的疗效和安全性(AD-301:NCT02118766;AD-302:NCT021187.92)。至少对2个SPS观测值进行了平均,以获得可接受的重新测试可靠性。结果:对于AD-301的569名患者和AD-302的561名患者,至少有2个基线观察结果可用。瘙痒改善的中位时间(SPS评分⩽1,与基线相比至少改善1分)使用crisaborole比使用赋形剂更短(AD-301:5.0 vs.10.0 d、 P=0.0003;AD-302:6.0与9.0 d、 P=0.0087)。在第4周,与载体治疗的患者相比,更多的crisaborole治疗的患者出现瘙痒改善(AD-301:37%对21%,P<0.0001;AD-302:34%对21%,P=0.0006),crisaborol治疗的平均瘙痒评分低于载体治疗(AD-301:0.97对1.28,<0.0001;AD-302:1.08对1.35,P<0.0001),与赋形剂治疗的患者相比,更多的crisaborole治疗的患者出现了临床重要的瘙痒反应(AD-301:75%对57%,P<0.0001;AD-302:72%对64%,P=0.00828)。结论:这些扩展分析表明,接受crisaborol治疗的患者在AD相关瘙痒方面得到了快速且临床相关的改善。
{"title":"Effect of crisaborole topical ointment, 2%, on atopic dermatitis–associated pruritus: an extended analysis of 2 phase 3 clinical trials","authors":"G. Yosipovitch, E. Simpson, H. Tan, R. Gerber, T. Luger, S. Ständer, W. Tom, J. Cappelleri, A. Bushmakin, W. Ports, A. Tallman","doi":"10.1097/itx.0000000000000012","DOIUrl":"https://doi.org/10.1097/itx.0000000000000012","url":null,"abstract":"Introduction: Pruritus is an essential feature of atopic dermatitis (AD) and is widely considered the most distressing symptom. Crisaborole ointment is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate AD. The efficacy of crisaborole for AD-associated pruritus was assessed in 2 phase 3 trials using the Severity of Pruritus Scale (SPS). Post hoc validation of the SPS identified that 1 SPS observation provided inadequate test-retest reliability. Therefore, extended analyses were conducted using at least 2 SPS observations for robust assessment of pruritus in the phase 3 crisaborole trials. Methods: Data were analyzed from 2 identically designed, vehicle-controlled, double-blind, phase 3 trials designed to investigate the efficacy and safety of crisaborole in AD patients aged 2 years and above (AD-301: NCT02118766; AD-302: NCT02118792). At least 2 SPS observations were averaged for acceptable test-retest reliability. Results: At least 2 baseline observations were available for 569 patients in AD-301 and 561 patients in AD-302. Median time to pruritus improvement (SPS score ⩽1 with at least 1-point improvement from baseline) was shorter with crisaborole than with vehicle (AD-301: 5.0 vs. 10.0 d, P=0.0003; AD-302: 6.0 vs. 9.0 d, P=0.0087). At week 4, more crisaborole-treated patients than vehicle-treated patients experienced pruritus improvement (AD-301: 37% vs. 21%, P<0.0001; AD-302: 34% vs. 21%, P=0.0006), mean pruritus scores were lower with crisaborole than with vehicle (AD-301: 0.97 vs. 1.28, P<0.0001; AD-302: 1.08 vs. 1.35, P<0.0001), and more crisaborole-treated patients than vehicle-treated patients experienced a clinically important pruritus response (AD-301: 75% vs. 57%, P<0.0001; AD-302: 72% vs. 64%, P=0.0828). Conclusions: These extended analyses show that patients treated with crisaborole experienced rapid and clinically relevant improvement in AD-associated pruritus.","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"226 24","pages":"e12"},"PeriodicalIF":0.0,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/itx.0000000000000012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41258805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Evaluation of the symptom of itch ambulatory office-based care in the United States 美国基于门诊护理的瘙痒症状评估
Pub Date : 2018-06-01 DOI: 10.1097/itx.0000000000000015
A. Fleischer
Introduction: This study was designed to assess the characteristics of visits for itch from a cross-sectional study of office-based ambulatory care in the United States. Methods: To characterize itch as a symptom, ambulatory visits from the 1993 to 2015 National Ambulatory Medical Care Survey were analyzed when they included “itching” as a symptom or itch as a diagnosis code (ICD-9-CM 692.X). Results: This study finds 129 million itch visits occurred, averaging 5.6 million visits per year. There is seasonality to itch visits, with the largest numbers occurring in summer and fewest in winter. Vulvovaginal conditions including candidiasis and vaginitis and vulvovaginitis are commonly associated with itching, yet under-represented in the dermatology literature. Discussion: These data provide insights for further investigation into the burden of itch-related diseases.
简介:本研究旨在评估美国基于办公室门诊护理的横断面研究中瘙痒就诊的特征。方法:为了将瘙痒作为一种症状,分析了1993年至2015年全国门诊医疗调查中将“瘙痒”作为一种症状或将瘙痒作为诊断代码(ICD-9-CM 692.X)的门诊就诊情况。结果:这项研究发现有1.29亿次瘙痒就诊,平均每年560万次。瘙痒有季节性,夏季最多,冬季最少。包括念珠菌病、阴道炎和外阴阴道炎在内的外阴阴道疾病通常与瘙痒有关,但在皮肤病学文献中代表性不足。讨论:这些数据为进一步调查瘙痒相关疾病的负担提供了见解。
{"title":"Evaluation of the symptom of itch ambulatory office-based care in the United States","authors":"A. Fleischer","doi":"10.1097/itx.0000000000000015","DOIUrl":"https://doi.org/10.1097/itx.0000000000000015","url":null,"abstract":"Introduction: This study was designed to assess the characteristics of visits for itch from a cross-sectional study of office-based ambulatory care in the United States. Methods: To characterize itch as a symptom, ambulatory visits from the 1993 to 2015 National Ambulatory Medical Care Survey were analyzed when they included “itching” as a symptom or itch as a diagnosis code (ICD-9-CM 692.X). Results: This study finds 129 million itch visits occurred, averaging 5.6 million visits per year. There is seasonality to itch visits, with the largest numbers occurring in summer and fewest in winter. Vulvovaginal conditions including candidiasis and vaginitis and vulvovaginitis are commonly associated with itching, yet under-represented in the dermatology literature. Discussion: These data provide insights for further investigation into the burden of itch-related diseases.","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"3 1","pages":"e15"},"PeriodicalIF":0.0,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/itx.0000000000000015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43556773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
9th World Congress on Itch report 第九届世界瘙痒大会报告
Pub Date : 2018-06-01 DOI: 10.1097/ITX.0000000000000014
K. M. Sanders, L. Nattkemper
{"title":"9th World Congress on Itch report","authors":"K. M. Sanders, L. Nattkemper","doi":"10.1097/ITX.0000000000000014","DOIUrl":"https://doi.org/10.1097/ITX.0000000000000014","url":null,"abstract":"","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/ITX.0000000000000014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44483384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mrgprs activation is required for chronic itch conditions in mice. Mrgprs激活是小鼠慢性瘙痒条件所必需的。
Pub Date : 2017-12-01 DOI: 10.1097/itx.0000000000000009
Yuyan Zhu, Claire E Hanson, Qin Liu, Liang Han

Introduction: Chronic itch has been drawing much attention due to its clinical significance and the complexity of its mechanisms. To facilitate the development of anti-itch strategies, it is necessary to investigate the key players in itch sensation under chronic itch conditions. Several members of the Mrgpr family were identified as itch receptors that detect cutaneous pruritogens in primary sensory neurons. However, the role of Mrgprs in chronic itch conditions has not been well described.

Methods: Scratching behaviors of WT and Mrgpr-clusterΔ-/- mice were examined in dry skin model and contact dermatitis model to examine the role of Mrgpr genes in mediating chronic itch sensation. Scratching behaviors of the mice were also examined in allergic itch model. Real-time PCR were performed to examine the expression level of MrgprA3 and MrgprC11 under naïve and dry skin conditions. The MrgprA3+ itch-sensing fibers were labeled by tdTomato fluorescence in Mrgpra3GFP-Cre; ROSA26tdTomato mice, and the morphology and density of those fibers in the epidermis were analyzed under dry skin condition.

Results: We showed that deleting a cluster of Mrgpr genes in mice reduced scratching behavior severely under two chronic itch conditions, namely dry skin and contact dermatitis, and the allergic itch condition. Moreover, the gene expressions of itch receptors MrgprA3 and MrgprC11 in dorsal root ganglia (DRG) were upregulated significantly under dry skin condition. Consistently, the percentage of MrgprA3+ itch-sensing neurons was increased as well. We also observed hyperinnervation of MrgprA3+ itch-sensing fibers in the epidermis of the skin under dry skin condition.

Discussion: We demonstrate that Mrgprs play important roles in mediating chronic itch and allergic itch. These findings enrich our knowledge of itch mechanism and may lead to the development of novel therapeutic approach to combat itch.

慢性瘙痒因其临床意义和机制的复杂性而备受关注。为了促进抗痒策略的发展,有必要研究慢性瘙痒条件下瘙痒感觉的关键因素。Mrgpr家族的几个成员被鉴定为在初级感觉神经元中检测皮肤瘙痒原的瘙痒受体。然而,Mrgprs在慢性瘙痒中的作用尚未得到很好的描述。方法:采用干性皮肤模型和接触性皮炎模型,观察WT和Mrgpr-clusterΔ-/-小鼠的抓痒行为,探讨Mrgpr基因在慢性瘙痒感觉中的作用。在过敏性瘙痒模型中观察小鼠抓痒行为。采用Real-time PCR检测naïve和干燥皮肤条件下MrgprA3和MrgprC11的表达水平。MrgprA3+瘙痒敏感纤维在Mrgpra3GFP-Cre中用tdTomato荧光标记;在干燥皮肤条件下,对ROSA26tdTomato小鼠表皮纤维的形态和密度进行了分析。结果:我们发现,在两种慢性瘙痒条件下,即皮肤干燥和接触性皮炎,以及过敏性瘙痒条件下,删除Mrgpr基因簇严重减少了小鼠的抓挠行为。此外,干燥皮肤条件下,瘙痒受体MrgprA3和MrgprC11在背根神经节(DRG)的基因表达显著上调。与此同时,MrgprA3+瘙痒感知神经元的比例也有所增加。我们还观察到,在皮肤干燥状态下,皮肤表皮中MrgprA3+瘙痒感应纤维的神经过度支配。讨论:我们证明Mrgprs在慢性瘙痒和过敏性瘙痒中发挥重要作用。这些发现丰富了我们对瘙痒机制的认识,并可能导致新的治疗方法的发展,以对抗瘙痒。
{"title":"Mrgprs activation is required for chronic itch conditions in mice.","authors":"Yuyan Zhu,&nbsp;Claire E Hanson,&nbsp;Qin Liu,&nbsp;Liang Han","doi":"10.1097/itx.0000000000000009","DOIUrl":"https://doi.org/10.1097/itx.0000000000000009","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic itch has been drawing much attention due to its clinical significance and the complexity of its mechanisms. To facilitate the development of anti-itch strategies, it is necessary to investigate the key players in itch sensation under chronic itch conditions. Several members of the Mrgpr family were identified as itch receptors that detect cutaneous pruritogens in primary sensory neurons. However, the role of Mrgprs in chronic itch conditions has not been well described.</p><p><strong>Methods: </strong>Scratching behaviors of WT and <i>Mrgpr-clusterΔ<sup>-/-</sup></i> mice were examined in dry skin model and contact dermatitis model to examine the role of <i>Mrgpr</i> genes in mediating chronic itch sensation. Scratching behaviors of the mice were also examined in allergic itch model. Real-time PCR were performed to examine the expression level of MrgprA3 and MrgprC11 under naïve and dry skin conditions. The MrgprA3<sup>+</sup> itch-sensing fibers were labeled by tdTomato fluorescence in <i>Mrgpra3<sup>GFP-Cre</sup>; ROSA26<sup>tdTomato</sup></i> mice, and the morphology and density of those fibers in the epidermis were analyzed under dry skin condition.</p><p><strong>Results: </strong>We showed that deleting a cluster of <i>Mrgpr</i> genes in mice reduced scratching behavior severely under two chronic itch conditions, namely dry skin and contact dermatitis, and the allergic itch condition. Moreover, the gene expressions of itch receptors MrgprA3 and MrgprC11 in dorsal root ganglia (DRG) were upregulated significantly under dry skin condition. Consistently, the percentage of MrgprA3<sup>+</sup> itch-sensing neurons was increased as well. We also observed hyperinnervation of MrgprA3<sup>+</sup> itch-sensing fibers in the epidermis of the skin under dry skin condition.</p><p><strong>Discussion: </strong>We demonstrate that Mrgprs play important roles in mediating chronic itch and allergic itch. These findings enrich our knowledge of itch mechanism and may lead to the development of novel therapeutic approach to combat itch.</p>","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"2 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/itx.0000000000000009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35945858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
A prospective case of postherpetic itch monitored by quantitative sensory testing for 1 year while undergoing 8% topical capsaicin treatments 在接受8%的局部辣椒素治疗的同时,通过定量感官测试监测1年的带状疱疹后瘙痒的前瞻性病例
Pub Date : 2017-11-01 DOI: 10.1097/itx.0000000000000008
H. H. Andersen, L. Arendt-Nielsen, G. Yosipovitch, J. Elberling
Following reactivation of a latent ganglionic varicella zoster virus and skin eruption in the corresponding dermatome(s) ∼20% of patients develop chronic postherpetic neuralgia. A subset of these patients develop severe and often intractable chronic postherpetic itch in the affected area. However, this is rarely studied and little is known about its epidemiology, pathogenesis, and management. In this case study we followed a patient with moderate to severe chronic postherpetic itch characterized by pure itch sensation, using standardized quantitative sensory testing and observed a profound loss-of-function for C-fibers, A&dgr;-fibers, and A&bgr;-fibers within the affected area. The testing was conducted before, during, and after 8% topical capsaicin treatments applied in 4 cycles (3 months apart) over the course of ∼1 year. During this period the hypoesthesia gradually normalized, but heat hypoalgesia remained unchanged. The 8% topical capsaicin had a good and long lasting antipruritic effect eventually resulting in complete resolution of the itch in parallel with partial recovery of initial hypoesthesia, particularly for warmth and cold detection, likely unrelated to the treatments.
潜伏性神经节型水痘-带状疱疹病毒再激活后,相应皮肤组出现皮疹,约20%的患者发展为慢性带状疱疹后神经痛。这些患者中有一部分在患处出现严重且往往难以治愈的慢性疱疹后瘙痒。然而,很少对其进行研究,对其流行病学、发病机制和管理也知之甚少。在本病例研究中,我们跟踪了一名以纯粹瘙痒感为特征的中度至重度慢性带状疱疹后瘙痒患者,使用标准化定量感觉测试,观察到C纤维、a&dgr的功能严重丧失-纤维和A&bgr-受影响区域内的纤维。该测试在4个周期内施用8%的局部辣椒素治疗之前、期间和之后进行(3 间隔数月)持续一年。在此期间,感觉减退逐渐恢复正常,但热痛觉减退没有改变。8%的局部辣椒素具有良好且持久的止痒效果,最终导致瘙痒完全消退,同时部分恢复了最初的感觉迟钝,特别是在温暖和寒冷的检测方面,这可能与治疗无关。
{"title":"A prospective case of postherpetic itch monitored by quantitative sensory testing for 1 year while undergoing 8% topical capsaicin treatments","authors":"H. H. Andersen, L. Arendt-Nielsen, G. Yosipovitch, J. Elberling","doi":"10.1097/itx.0000000000000008","DOIUrl":"https://doi.org/10.1097/itx.0000000000000008","url":null,"abstract":"Following reactivation of a latent ganglionic varicella zoster virus and skin eruption in the corresponding dermatome(s) ∼20% of patients develop chronic postherpetic neuralgia. A subset of these patients develop severe and often intractable chronic postherpetic itch in the affected area. However, this is rarely studied and little is known about its epidemiology, pathogenesis, and management. In this case study we followed a patient with moderate to severe chronic postherpetic itch characterized by pure itch sensation, using standardized quantitative sensory testing and observed a profound loss-of-function for C-fibers, A&dgr;-fibers, and A&bgr;-fibers within the affected area. The testing was conducted before, during, and after 8% topical capsaicin treatments applied in 4 cycles (3 months apart) over the course of ∼1 year. During this period the hypoesthesia gradually normalized, but heat hypoalgesia remained unchanged. The 8% topical capsaicin had a good and long lasting antipruritic effect eventually resulting in complete resolution of the itch in parallel with partial recovery of initial hypoesthesia, particularly for warmth and cold detection, likely unrelated to the treatments.","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"2 1","pages":"e8"},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/itx.0000000000000008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44237469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Are sex and history of pruritic skin conditions factors which affect the phenomenon of visually evoked itch? An exploratory study 皮肤瘙痒的性别和病史是否是影响视觉诱发瘙痒现象的因素?探索性研究
Pub Date : 2017-11-01 DOI: 10.1097/itx.0000000000000010
D. Lloyd, R. Dodd, C. Higgins, M. Burke, F. McGlone
Introduction: We have previously shown that sensations of itch and the scratch response can be evoked using itch-related images. However, we did not determine whether individual differences in a person’s experience of itch could moderate this effect. This exploratory study aimed to determine whether sex or a history of pruritic skin conditions (PSCs) could influence the effects of visually evoked itch and scratch. Methods: Forty-one participants (19 males; 16 with a history of PSCs) viewed static images that could either be itch or nonitch related. These were further separated by picture type: “skin contact” (ants crawling on the hand vs. a butterfly on the finger); “skin response” (scratching an insect bite vs. washing the hands); “skin condition” (psoriasis vs. freckles) or “context only” (insects vs. birds). Images were rated using a 10-point scale by answering: “How itchy do you feel?” (Self-rating) and “How itchy do you think the person in the picture feels?” (Other-rating). Frequency and location of scratching was also recorded. Results: The highest itch scores were to itch-related skin contact pictures. Females gave higher itch ratings than males, and people with a history of PSCs gave higher itch ratings when viewing images of people scratching. There was no correlation between itch ratings and scratch response, and no relationship between body site viewed and location of scratching. Discussion: There is a heightened response to itch-related cues in females and those with PSCs, indicating a more centrally mediated pathway bringing subconscious itch sensations into conscious awareness in these populations. These findings could influence personalized treatment interventions aimed at reducing awareness of itch sensations in susceptible individuals.
我们之前已经证明,瘙痒的感觉和抓挠反应可以用瘙痒相关的图像被唤起。然而,我们并没有确定一个人的瘙痒经历的个体差异是否可以缓和这种影响。本探索性研究旨在确定性别或瘙痒性皮肤状况(PSCs)的历史是否会影响视觉诱发瘙痒和抓伤的效果。方法:41例受试者(男性19例;(16例有psc病史)查看了可能与瘙痒或非瘙痒相关的静态图像。这些照片根据图片类型进一步分开:“皮肤接触”(蚂蚁在手上爬行,蝴蝶在手指上);“皮肤反应”(抓挠昆虫叮咬vs.洗手);“皮肤状况”(牛皮癣vs雀斑)或“仅限环境”(昆虫vs鸟类)。通过回答:“你觉得有多痒?”(自我评价)和“你觉得照片中的人有多痒?””(其他评级)。同时记录抓挠的频率和位置。结果:瘙痒评分最高的是与瘙痒相关的皮肤接触图片。女性对瘙痒的评分高于男性,而有psc病史的人在观看人们抓挠的图像时,对瘙痒的评分更高。瘙痒评分和抓痕反应之间没有相关性,观察身体部位和抓痕位置之间也没有相关性。讨论:在女性和具有PSCs的人群中,对瘙痒相关线索的反应增强,表明在这些人群中,有一种更集中的介导途径将潜意识的瘙痒感觉带入有意识的意识。这些发现可能会影响个性化的治疗干预措施,旨在减少易感个体对瘙痒感觉的认识。
{"title":"Are sex and history of pruritic skin conditions factors which affect the phenomenon of visually evoked itch? An exploratory study","authors":"D. Lloyd, R. Dodd, C. Higgins, M. Burke, F. McGlone","doi":"10.1097/itx.0000000000000010","DOIUrl":"https://doi.org/10.1097/itx.0000000000000010","url":null,"abstract":"Introduction: We have previously shown that sensations of itch and the scratch response can be evoked using itch-related images. However, we did not determine whether individual differences in a person’s experience of itch could moderate this effect. This exploratory study aimed to determine whether sex or a history of pruritic skin conditions (PSCs) could influence the effects of visually evoked itch and scratch. Methods: Forty-one participants (19 males; 16 with a history of PSCs) viewed static images that could either be itch or nonitch related. These were further separated by picture type: “skin contact” (ants crawling on the hand vs. a butterfly on the finger); “skin response” (scratching an insect bite vs. washing the hands); “skin condition” (psoriasis vs. freckles) or “context only” (insects vs. birds). Images were rated using a 10-point scale by answering: “How itchy do you feel?” (Self-rating) and “How itchy do you think the person in the picture feels?” (Other-rating). Frequency and location of scratching was also recorded. Results: The highest itch scores were to itch-related skin contact pictures. Females gave higher itch ratings than males, and people with a history of PSCs gave higher itch ratings when viewing images of people scratching. There was no correlation between itch ratings and scratch response, and no relationship between body site viewed and location of scratching. Discussion: There is a heightened response to itch-related cues in females and those with PSCs, indicating a more centrally mediated pathway bringing subconscious itch sensations into conscious awareness in these populations. These findings could influence personalized treatment interventions aimed at reducing awareness of itch sensations in susceptible individuals.","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"2 1","pages":"e10"},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45326324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Suppression of scratching-induced pleasurable sensation by compression nerve blocking and its association with itch relief. 通过压迫神经阻滞抑制挠引起的愉悦感觉及其与瘙痒缓解的关系。
Pub Date : 2017-09-01 Epub Date: 2017-10-02 DOI: 10.1097/itx.0000000000000007
Hideki Mochizuki, Alina Shevchenko, Leigh A Nattkemper, Rodrigo Valdes-Rodriguez, Gil Yosipovitch

Itch can be suppressed by scratching. At the same time, scratching evokes a pleasurable sensation. In the present study, we investigated the peripheral mechanism of scratching-induced pleasurability and its association with itch relief using compression nerve block. We found that myelinated nerve fibers (Aβ-fibers and possibly Aδ-fibers), are involved in transmission of scratching-induced pleasurability. We observed that itch relief effect was the same regardless of whether the pleasurable sensation was evoked by scratching an itch, indicating that pleasure is not a necessary component to induce itch relief. This is the first study to investigate the peripheral mechanism of scratching-induced pleasurability and itch relief.

瘙痒可以通过抓挠来抑制。同时,抓挠唤起一种愉悦的感觉。在本研究中,我们研究了抓挠引起的愉悦感的外周机制及其与使用压迫神经阻滞缓解瘙痒的关系。我们发现髓鞘神经纤维(a - β-纤维和可能的a - δ-纤维)参与了挠性快感的传递。我们观察到,不管挠痒是否引起愉悦感,瘙痒缓解效果都是一样的,这表明愉悦感不是诱导瘙痒缓解的必要成分。这是第一个研究挠引起的愉悦和瘙痒缓解的外周机制的研究。
{"title":"Suppression of scratching-induced pleasurable sensation by compression nerve blocking and its association with itch relief.","authors":"Hideki Mochizuki,&nbsp;Alina Shevchenko,&nbsp;Leigh A Nattkemper,&nbsp;Rodrigo Valdes-Rodriguez,&nbsp;Gil Yosipovitch","doi":"10.1097/itx.0000000000000007","DOIUrl":"https://doi.org/10.1097/itx.0000000000000007","url":null,"abstract":"<p><p>Itch can be suppressed by scratching. At the same time, scratching evokes a pleasurable sensation. In the present study, we investigated the peripheral mechanism of scratching-induced pleasurability and its association with itch relief using compression nerve block. We found that myelinated nerve fibers (Aβ-fibers and possibly Aδ-fibers), are involved in transmission of scratching-induced pleasurability. We observed that itch relief effect was the same regardless of whether the pleasurable sensation was evoked by scratching an itch, indicating that pleasure is not a necessary component to induce itch relief. This is the first study to investigate the peripheral mechanism of scratching-induced pleasurability and itch relief.</p>","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"2 2","pages":"e7"},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/itx.0000000000000007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37018875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Management of chronic pruritus: from the dermatological office to the specialized itch center: a review. 慢性瘙痒症的治疗:从皮肤科诊室到专门的瘙痒中心:综述。
Pub Date : 2017-09-01 Epub Date: 2017-10-02 DOI: 10.1097/itx.0000000000000006
Manuel P Pereira, Sabine Steinke, Philipp Bruland, Hartmut F Ständer, Martin Dugas, Matthias Augustin, Sonja Ständer

Patient care for those affected by chronic pruritus is remarkably complex due to its high prevalence and multifactorial nature. It requires a comprehensive assessment of the patient's medical history, extensive diagnostic procedures, and long treatment duration, including management of possible accompanying disorders such as sleep disturbances and mental distress. It is important to prioritize patient's needs when developing a therapeutic treatment plan. Standardized questionnaires and scales should be used to better analyze the patient history, quality of life, symptom intensity, and course of treatment. These can be distributed via digital platforms, allowing for more effective communication between the treating agents and gathering of large volumes of data in central databases. In today's health care system, it is essential for physicians with itch-related specializations and specialized itch centers to cooperate. It is thus crucial to focus efforts on the further development of specialized treatment centers and training courses for medical practitioners. There are, however, various regulatory and economic barriers to overcome in the modern health care system before patients with chronic pruritus can be offered the best possible care. Accordingly, health care authorities should be made aware of the difficulties associated with the management of chronic pruritus and of the high individual and societal burden it represents.

由于慢性瘙痒症的高发病率和多因素性质,对患者的护理非常复杂。它要求对患者的病史进行全面评估、进行广泛的诊断程序和长时间的治疗,包括处理可能出现的伴随疾病,如睡眠障碍和精神痛苦。在制定治疗方案时,必须优先考虑患者的需求。应使用标准化的问卷和量表来更好地分析患者的病史、生活质量、症状强度和治疗过程。这些问卷和量表可以通过数字平台发布,从而使治疗人员之间的沟通更加有效,并将大量数据收集到中央数据库中。在当今的医疗保健系统中,与瘙痒相关的专业医生和专业瘙痒中心必须开展合作。因此,将工作重点放在进一步发展专业治疗中心和医疗从业人员培训课程上至关重要。然而,在为慢性瘙痒症患者提供最佳治疗之前,现代医疗保健系统还需要克服各种监管和经济障碍。因此,应让医疗机构认识到与慢性瘙痒症治疗相关的困难,以及慢性瘙痒症给个人和社会带来的沉重负担。
{"title":"Management of chronic pruritus: from the dermatological office to the specialized itch center: a review.","authors":"Manuel P Pereira, Sabine Steinke, Philipp Bruland, Hartmut F Ständer, Martin Dugas, Matthias Augustin, Sonja Ständer","doi":"10.1097/itx.0000000000000006","DOIUrl":"10.1097/itx.0000000000000006","url":null,"abstract":"<p><p>Patient care for those affected by chronic pruritus is remarkably complex due to its high prevalence and multifactorial nature. It requires a comprehensive assessment of the patient's medical history, extensive diagnostic procedures, and long treatment duration, including management of possible accompanying disorders such as sleep disturbances and mental distress. It is important to prioritize patient's needs when developing a therapeutic treatment plan. Standardized questionnaires and scales should be used to better analyze the patient history, quality of life, symptom intensity, and course of treatment. These can be distributed via digital platforms, allowing for more effective communication between the treating agents and gathering of large volumes of data in central databases. In today's health care system, it is essential for physicians with itch-related specializations and specialized itch centers to cooperate. It is thus crucial to focus efforts on the further development of specialized treatment centers and training courses for medical practitioners. There are, however, various regulatory and economic barriers to overcome in the modern health care system before patients with chronic pruritus can be offered the best possible care. Accordingly, health care authorities should be made aware of the difficulties associated with the management of chronic pruritus and of the high individual and societal burden it represents.</p>","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"2 2","pages":"e6"},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8b/53/itx-2-e6.PMC6372054.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37018874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brief communication: MRGPRX2, atopic dermatitis and red man syndrome. 简要交流:MRGPRX2、特应性皮炎和红人综合征。
Pub Date : 2017-03-01 DOI: 10.1097/itx.0000000000000005
Ehsan Azimi, Vemuri B Reddy, Ethan A Lerner

Vancoymycin causes red man syndrome, an itchy erythematous eruption involving the face, neck and upper torso. Atopic dermatitis also manifests itch and erythema, and staphylococcus δ-toxin contributes to this process. The antibiotic and toxin each provoke mast cell degranulation but the mechanism had not been understood. We have determined that these compounds evoke degranulation via interaction with the same receptor, MRGPRX2, on mast cells. A receptor antagonist inhibits this process. Antagonists of this receptor may have therapeutic potential.

万古霉素会导致红人综合征,这是一种涉及面部、颈部和上半身的瘙痒性红斑。特应性皮炎也会出现瘙痒和红斑,而葡萄球菌δ毒素也会导致这一过程。抗生素和毒素都会引起肥大细胞脱颗粒,但其机制尚不清楚。我们已经确定,这些化合物是通过与肥大细胞上的相同受体 MRGPRX2 相互作用而诱发脱颗粒的。受体拮抗剂可抑制这一过程。这种受体的拮抗剂可能具有治疗潜力。
{"title":"Brief communication: MRGPRX2, atopic dermatitis and red man syndrome.","authors":"Ehsan Azimi, Vemuri B Reddy, Ethan A Lerner","doi":"10.1097/itx.0000000000000005","DOIUrl":"10.1097/itx.0000000000000005","url":null,"abstract":"<p><p>Vancoymycin causes red man syndrome, an itchy erythematous eruption involving the face, neck and upper torso. Atopic dermatitis also manifests itch and erythema, and staphylococcus δ-toxin contributes to this process. The antibiotic and toxin each provoke mast cell degranulation but the mechanism had not been understood. We have determined that these compounds evoke degranulation via interaction with the same receptor, MRGPRX2, on mast cells. A receptor antagonist inhibits this process. Antagonists of this receptor may have therapeutic potential.</p>","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fc/f6/itx-2-e5.PMC5375112.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34877110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Itch (Philadelphia, Pa.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1